Time to positivity of blood culture association with clinical presentation, prognosis and ESBL-production in Escherichia coli bacteremia

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 9, 2012, Pages 2191-2195

  Alvarez R ^a,b   Vinas Castillo L ^a,c   Lepe Jimenez J A ^a   Garcia Cabrera E ^a,c   Cisneros Herreros, J M ^a,c  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b Instituto de Biomedicina de Sevilla   (Spain)

^c Institute of Biomedical Researches Seville   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EXTENDED SPECTRUM BETA LACTAMASE;

ADULT; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BLOOD CULTURE; CLINICAL FEATURE; DEATH; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE SEPSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PARAMETERS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SEPSIS; SEPTIC SHOCK; TIME TO POSITIVITY;

EID: 84866367832     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-012-1554-5     Document Type: Article

References (19)

1. Kang CI, Song JH, Chung DR, Peck KR, Ko KS, Yeom JS et al (2011) Risk factors and pathogenic significance of severe sepsis and septic shock in 2286 patients with gram-negative bacteremia. J Infect 62(1):26-33
2. Peralta G, Sanchez MB, Garrido JC, De Benito I, Canos ME, Martínez-Martínez L, RoizMP (2007) Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia. J Antimicrob Chemother 60(4):855-863
3. Lefort A, Panhard X, Clermont O, Woerther PL, Branger C, Mentre F, Fantin B, Wolff M, Denamurs E, COLIBAFI Group (2011) Host factors and portal of entry outweigh bacterial determinants to predict the severity of Escherichia coli bacteremia. J Clin Microbiol 49 (3):777-783
4. Blot F, Schmidt E, Nitenberg G, Trancrède C, Leclercq B, Laplanche A, Andremont A (1998) Earlier positivity of centralvenous versus peripheral-blood cultures is highly predictive of catheter related sepsis. J Clin Microbiol 36:105-109
5. Haime-Cohen Y, Vellozzi EM, Rubin LG (2002) Initial concentration of Staphylococcus epidermidis in simulated pediatric blood cultures correlates with time to positive results with the automated, continuously monitored BACTEC blood culture system. J Clin Microbiol 40:898-901
6. Kim J, Gragson DB, Ross T, Lauphand KB (2010) Time to blood culture positivity in Staphylococcus aureus bacteremia: association with 30-day mortality. British Infection Society J Infect 61:197-204
7. Martínez JA, Soto S, Fabrega A, Almela M, Mensa J, Soriano A, Marco F, Jiménez de Anta MT, Vila J (2006) Relationship of phylogenetic background, biofilm production and time to detection of growth in blood culture vials with clinical variables and prognosis associated with Escherichia coli. J Clin Microbiol 44 (4):1468-4
8. Peralta G, Roiz MP, Sánchez MB, Garrido JC, Ceballos B, Rodríguez-Lera MJ, Mateos F, De Benito I (2007) Time-topositivity in patients with Escherichia coli bacteremia. Clin Microbiol Infect 13:1077-1082
9. Khatib R, Riederer K, Saeed S, Johnson LB, Fakih MG, Sharma M, Tabriz MS, Khosrovaneh A (2005) Time to positivity in Staphylococcus aureus bacteremia: possible correlation with the source and outcome of infection. Clin Infect Dis 41:594-598
10. Marra AR, Edmond MB, Forbes BA, Wenzel RP, Bearman GM (2006) Time to blood culture positivity as predictor of clinical outcome of Staphylococcus aureus bloodstream infection. J Clin Microbiol 44(4):1342-1346
11. Peralta G, Rodriguez-Lera MJ, Garrido JC, Ansorena L, Roiz MP (2006) Time to positivity in blood cultures of adults with Streptococcus pneumoniae bacteremia. BMC Infect Dis 27(6):79
12. Bo SN, Bo J, Ning YZ, Zhao Y, Lu XL, Yang JY, Zhu X, Yao GQ (2011) Relationship between time to positivity of blood culture with clinical characteristics and hospital mortality in patients with Escherichia coli bacteremia. Chin Med J 124(3):330-333
13. Pitout JD, Laupland KB (2008) Extended-spectrum lactamase producing Enterobacteriaceae: an emerging public-health problem. Lancet Infect Dis 8:150-166
14. Horan TC, Andrus M, Dudeck MA (2002) DC/NHSN surveillance definition of health care associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36 (5):309-332
15. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101(6):1644-1655
16. Paterson DL, Ko WC, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, Mulazimoglu L, Trenholme G, Klugman KP, Bonomo RA, Rice LB, Wagener MM, McCormack JG, Yu VL (2004) International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial Infections. Ann Intern Med 140:26-32
17. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic co-morbidity in longitudinal studies: development and validation. J Chron Dis 40:373-383
18. Bagel S, Hüllen V, Wiedemann B, Heisin P (1999) Impact of gyrA and parC mutations on quinoloneresistance, doubling time and supercoiling degree or Escherichia coli. Antimicrob Agents Chemother 43:868-875
19. Vila J, Simon K, Ruiz J, Horcajada JP, Velasco M, Barranco M, Moreno A, Mensa J (2002) Are quinolone-resistant uropathogenic Escherichia coli less virulent? J Infect Dis 186:1039-1042